ArticleFrontiers in cardiovascular medicine2023

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials.

An Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.